This expanded dataset will clarify Retatrutides full potential, including whether the weight loss trajectory continues beyond the 48-week Phase 2 endpoint
Patients who have undergone thyroidectomy for thyroid cancer, Graves' disease, or other conditions should expect that weight loss on semaglutide will plateau without sustained behavior change (diet and movement)
Staying hydrated, eating slowly, and focusing on protein and gentle carbohydrates can complement your injection schedule in managing early side effects during dose escalation
What the FDA briefing report said about the evidence
When considering any weight management medication, understanding its potential effects on the liver is important for patient safety
Popular tracking tools include: Patients can use simple charts or digital apps to record these numbers at home